Minute Insight: Phage-Based TB Diagnostic Demonstrates Capability

Actiphage, developed by PBD Biotech could be a key tool in the fight against tuberculosis.  

Minute Insight
• Source: Informa/Alamy

PBD Biotech, a Suffolk, UK-based diagnostics company, is trying to relieve the burden of tuberculosis diagnosis with its phage-based test, Actiphage.

According to the World Health Organization, tuberculosis is currently the 13th leading cause of death, and the second most infectious...

More from Minute Insights

More from Medtech Insight

US FDA Unveils Plans To Consolidate Support Services

 

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

‘UK Must Put Adoption On A Par With Innovation’

 
• By 

Market access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.